Hermas Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 07-12-2024
- Paid Up Capital ₹ 0.30 M
as on 07-12-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 51.36%
(FY 2022)
- Profit -7.94%
(FY 2022)
- Ebitda 31.71%
(FY 2022)
- Net Worth 10.48%
(FY 2022)
- Total Assets 2.14%
(FY 2022)
About Hermas Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Mushir Shaikh, Naim Azmi, and Mohammed Ashhad serve as directors at the Company.
- CIN/LLPIN
U74120MH2014PTC258834
- Company No.
258834
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hermas Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mushir Shaikh  | Director | 22-Oct-2014 | Current |
| Naim Azmi | Director | 22-Oct-2014 | Current |
| Mohammed Ashhad | Director | 14-Mar-2016 | Current |
Financial Performance of Hermas Biotech.
Hermas Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.36% increase. The company also saw a slight decrease in profitability, with a 7.94% decrease in profit. The company's net worth Soared by an impressive increase of 10.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hermas Biotech?
In 2022, Hermas Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hermas Biotech?
Unlock and access historical data on people associated with Hermas Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hermas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hermas Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
